Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey (Q36474120)

14 August 2017

Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey (English)

1 reference

Helicobacter pylori infectious disease

14 August 2017

0 references

1 reference

Yuksel Gumurdulu

1

1 reference

14 August 2017

Ender Serin

2

1 reference

14 August 2017

Birol Ozer

3

1 reference

14 August 2017

Fazilet Kayaselcuk

4

1 reference

14 August 2017

Kursat Ozsahin

5

1 reference

14 August 2017

Arif Mansur Cosar

6

1 reference

14 August 2017

Murat Gursoy

7

1 reference

14 August 2017

Gurden Gur

8

1 reference

14 August 2017

Ugur Yilmaz

9

1 reference

14 August 2017

Sedat Boyacioglu

10

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

World Journal of Gastroenterology

14 August 2017

1 reference

14 August 2017

10

1 reference

14 August 2017

5

1 reference

14 August 2017

668-671

1 reference

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Helicobacter pylori entry into human gastric epithelial cells: A potential determinant of virulence, persistence, and treatment failures.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Treatment after failure: the problem of "non-responders".

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Review: eradication of Helicobacter pylori. Problems and recommendations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Unidentified curved bacilli on gastric epithelium in active chronic gastritis

30 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

30 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Factors influencing the eradication of Helicobacter pylori with triple therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4716906

Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin

21 September 2018

1 reference

12 December 2020

Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication

1 reference

12 December 2020

Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India

1 reference

12 December 2020

A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer

1 reference

12 December 2020

Antimicrobial resistance in Helicobacter pylori: a global overview

1 reference

12 December 2020

pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism

1 reference

12 December 2020

Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing

1 reference

12 December 2020

Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy

1 reference

12 December 2020

Effect of lifestyle, smoking, and diet on development of intestinal metaplasia in H. pylori-positive subjects

1 reference

12 December 2020

Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group

1 reference

12 December 2020

Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V10.I5.668

1 reference

14 August 2017

1 reference

14 August 2017

1 reference